| Title |
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, April 2010
|
| DOI | 10.1007/s10549-010-0888-x |
| Pubmed ID | |
| Authors |
Tomohiko Aihara, Yuichi Takatsuka, Shozo Ohsumi, Kenjiro Aogi, Yasuo Hozumi, Shigeru Imoto, Hirofumi Mukai, Hiroji Iwata, Toru Watanabe, Chikako Shimizu, Kazuhiko Nakagami, Motoshi Tamura, Toshikazu Ito, Norikazu Masuda, Nobuo Ogino, Kazufumi Hisamatsu, Shoshu Mitsuyama, Hajime Abe, Shiro Tanaka, Takuhiro Yamaguchi, Yasuo Ohashi |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 3% |
| Japan | 1 | 1% |
| Unknown | 64 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 11 | 16% |
| Researcher | 10 | 15% |
| Student > Ph. D. Student | 7 | 10% |
| Other | 6 | 9% |
| Student > Postgraduate | 4 | 6% |
| Other | 10 | 15% |
| Unknown | 19 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 40% |
| Agricultural and Biological Sciences | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Nursing and Health Professions | 3 | 4% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Other | 7 | 10% |
| Unknown | 20 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2017.
All research outputs
#14,943,828
of 22,985,065 outputs
Outputs from Breast Cancer Research and Treatment
#3,213
of 4,675 outputs
Outputs of similar age
#77,309
of 95,665 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#37
of 42 outputs
Altmetric has tracked 22,985,065 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,675 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,665 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.